Package 0409-5084-11

{"route": ["INTRAVENOUS"], "spl_id": "a0763a23-5d1e-4fc3-9e3c-1a426fff42b0", "openfda": {"unii": ["9M416Z9QNR"], "rxcui": ["1659283", "1659287", "1659292", "1659294"], "spl_set_id": ["40d48c5d-650e-461b-a67b-7e65772d1b92"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (0409-5084-11)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-5084-13)", "package_ndc": "0409-5084-11", "marketing_start_date": "20051216"}], "brand_name": "TAZICEF", "product_id": "0409-5084_a0763a23-5d1e-4fc3-9e3c-1a426fff42b0", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "0409-5084", "generic_name": "CEFTAZIDIME", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAZICEF", "active_ingredients": [{"name": "CEFTAZIDIME", "strength": "2 g/1"}], "application_number": "ANDA062662", "marketing_category": "ANDA", "marketing_start_date": "20051216", "listing_expiration_date": "20261231"}